from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0313/-

LFCtreatmentdescriptionclass of inhibitor

0.450

Amikacinug/mL Amikacintranslation

-0.944

Cap5-10ug/mL Capreomycintranslation

-0.451

Rox10-50 ug/mL Roxithromycintranslation

-0.304

SM2-5 ug/mL Streptomycintranslation

0.348

Tet5-10 ug/mL Tetracyclinetranslation

-0.607

Rif0.2-5ug/mL Rifampicintranscription

-0.894

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.686

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.660

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.017

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.032

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.786

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.332

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.275

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.344

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.591

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.237

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.293

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.807

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.075

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.270

KCN5-20 ug/mL Potassium cyaniderespiration

-0.107

NaN30.2-2 mM Sodium aziderespiration

-1.125

Nigericin50 uM Nigericinrespiration

0.222

TRC10-150 ug/mL Triclosanrespiration

1.272

TRZ10-25 ug/mL Thioridazinerespiration

-0.529

Valinomycin0.5-10 uM Valinomycinrespiration

-1.086

ZnSO42 mM ZnSO4respiration

0.252

menadione6-10 ug/mL Menadionerespiration

-0.602

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.881

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-1.146

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.986

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.106

NRP_1Non-replicating persistence stage 1dosRassociated

-0.172

Amp0.2mg/mL AmpicillincellWall

-0.312

Cephalexin20-100 ug/mL CephalexincellWall

-0.601

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.088

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.219

EMB10-20 ug/mL EthambutolcellWall

0.426

Eta12-40 ug/mL EthionamidecellWall

1.132

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.113

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.686

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.174

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.475

BZA0.12 mg/mL BenzamidearomaticAmides

1.260

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.283

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.423

H2O24 mM hydrogen peroxideDNAdamaging

-0.409

Levo10 ug/mL LevofloxacinDNAdamaging

-0.430

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.390

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.119

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.617

UVUV-irradiationDNAdamaging

-0.776

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.889

Antimycin12.5-50 ug/mL Antimycin A?

-1.022

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.209

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.651

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.395

PA8240.2-2 ug/mL PA-824?

0.059

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.184

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.789

Verapamil50 uM Verapamil?

-1.249

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.626

methoxatin10-20 ug/mL Methoxatin?